Latest News
VivoSim Labs, Inc.
- VivoSim Labs Inc Estimates – LSX:A41083
- VivoSim Labs Extends NAMkind Platform with Human Disease
- VivoSim Labs expands human tissue platform to t...
- VivoSim (NASDAQ: VIVS) NAMkind™ Targets FDA’s New Testing Bar
Headlines from the last 30 days, linking to the original publishers. See all market news →